TipRanks
Solvonis Therapeutics (DE:J4I)
FRANKFURT:J4I
Germany Market
J4I
Solvonis Therapeutics
RESEARCH TOOLSreports

Solvonis Therapeutics (J4I) Income Statement

0 Followers

Solvonis Therapeutics Income Statement

Last quarter (Q4 2025), Solvonis Therapeutics's total revenue was £0.00, a decrease of -100.00% from the same quarter last year. In Q4, Solvonis Therapeutics's net income was £-4.12M. See Solvonis Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 0.00£ 0.00£ 587.00K£ 542.00K£ 219.00K
Gross Profit
£ 0.00£ 0.00£ -134.00K£ -51.00K£ 55.00K
Operating Expenses
£ 3.48M£ 1.38M£ 3.26M£ 2.66M£ 900.00K
Depreciation and Amortization
£ 0.00£ 0.00£ 177.00K£ 113.00K£ 46.00K
EBITDA
£ -5.74M£ -1.38M£ -2.94M£ -2.59M£ -900.00K
Operating Income
£ -3.48M£ -1.38M£ -2.21M£ -2.71M£ -845.00K
Other Income/Expenses
£ -2.26M£ -64.00K£ -910.00K£ -4.00K£ -109.00K
Pretax Income
£ -5.74M£ -1.45M£ -3.12M£ -2.71M£ -954.00K
Net Income
£ -5.74M£ -1.59M£ -3.12M£ -2.71M£ -954.00K
Per Share Metrics
Basic EPS
£ >-0.01£ >-0.01£ -0.03£ -0.03£ >-0.01
Diluted EPS
£ >-0.01£ >-0.01£ -0.03£ -0.03£ >-0.01
Weighted Average Shares Outstanding
 4.86B 1.16B 104.06M 103.59M 104.10M
Weighted Average Shares Outstanding (Diluted)
 4.86B 1.16B 104.06M 103.59M 104.10M
Currency in GBP

Solvonis Therapeutics Earnings and Revenue History